ESCRS - Death of Dr David Apple

Death of Dr David Apple

Death of Dr David Apple
Dr David Apple died on August 18, 2011 at the age of 69. 'David was a most assiduous and enthusiastic supporter of the ESCRS and each year he made many unique contributions to our understanding of the pathophysiology of lens implantation,' said Dr Emanuel Rosen, ESCRS Board member and a friend and colleague of Dr Apple's. 'David Apple combined a superb intellect with an encyclopaedic knowledge of ophthalmology and ophthalmic pathology a combination of talents that found an outlet in the practice of cataract surgery at the right time in its evolution. In recognition of his many achievements he was awarded the Ridley Gold Medal at the XVII ESCRS Congress, Vienna, Austria, in September 1999,' said Dr Rosen, 'We extend our sympathy and condolences to his wife Ann and all his friends and family.' A full obituary written by Dr Rosen, will appear in the October issue of EuroTimes.
Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...